Coccidioidomycosis in Allogeneic Stem Cell Transplant Recipients: Case Series and Review of the Literature

被引:7
|
作者
Saling, Christopher F. [1 ]
Gea-Banacloche, Juan [1 ]
Trickett, John S. [2 ]
Blair, Janis E. [1 ]
机构
[1] Mayo Clin, Div Infect Dis, Phoenix, AZ 85054 USA
[2] Mayo Clin, Dept Internal Med, Phoenix, AZ 85054 USA
关键词
coccidioidomycosis; Coccidioides; allogeneic stem cell transplant; bone marrow transplant; BONE-MARROW-TRANSPLANTATION; CONDITIONING REGIMENS; BLOOD; DIAGNOSIS; INFECTIONS; DISEASE;
D O I
10.3390/jof7050339
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coccidioides is an endemic fungus of the Southwest United States that causes the disease coccidioidomycosis. Immunocompromised persons are at increased risk for severe infection and dissemination. One such population is allogeneic bone marrow transplant (allo-HCT) recipients, but accounts of coccidioidal infection in these patients have rarely been documented. We present two cases of Coccidioides in allo-HCT recipients with good outcomes: one patient who developed pulmonary coccidioidomycosis in the late post-engraftment phase and another with known controlled disseminated infection at the time of transplant. A review of the literature identified 19 allo-HCT recipients with coccidioidomycosis. Due to the limited published literature, no guidelines have yet been established regarding optimal prophylaxis and treatment of Coccidioides infection in allo-HCT recipients. Candidates for transplantation should undergo a rigorous pre-transplant assessment to identify evidence of prior or active coccidioidomycosis. In our experience, patients who visit or live in Coccidioides-endemic areas should receive primary prophylaxis for at least the first 100 days post-transplant, and duration should be extended as long as the patient remains on immunosuppression. Those with prior infection should receive secondary prophylaxis while immunosuppressed. Patients with active infection should have treatment and stabilization of infection and continue anti-fungal treatment through immunosuppression.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature
    Bowman S.
    Stanek J.
    Bajwa R.
    Polishchuk V.
    Abu-Arja R.
    Rangarajan H.G.
    Clinical Hematology International, 2023, 5 (2-3) : 155 - 164
  • [2] Fludarabine and bradycardia in recipients of allogeneic stem cell transplant: a case series
    Philip, Chepsy C.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2015, 40 (02): : 104 - 106
  • [3] Coccidioidomycosis in hematopoietic stem cell transplant recipients
    Glenn, TJ
    Blair, JE
    Adams, RH
    MEDICAL MYCOLOGY, 2005, 43 (08) : 705 - 710
  • [4] Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature
    Padmanabhan, S.
    Battiwalla, M.
    Hahn, T.
    Ball, D.
    Paplham, P.
    Brown, K.
    Segal, B. H.
    McCarthy, P., Jr.
    Almyroudis, N. G.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (02) : 148 - 152
  • [5] West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: Case series and literature review
    Hong, DS
    Jacobson, KL
    Raad, II
    de Lima, M
    Anderlini, P
    Fuller, GN
    Ippoliti, C
    Cool, RM
    Leeds, NE
    Narvios, A
    Han, XY
    Padula, A
    Champlin, RE
    Hosing, C
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (08) : 1044 - 1049
  • [6] Identification and Treatment of Tuberculosis in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Review of the Literature
    Wang, Xiaodong
    Yu, Uet
    Li, Xiaonan
    Wang, Chunjing
    Zhang, Qian
    Yang, Chunlan
    Zhang, Xiaoling
    Zhang, Yu
    Wang, Ying
    Zheng, Yuejie
    Deng, Jikui
    Yang, Weiguo
    Liu, Guosheng
    Deng, Guofang
    Liu, Sixi
    Wen, Feiqiu
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 2641 - 2648
  • [7] Strongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature
    Iori, A. P.
    Ferretti, A.
    Gentile, G.
    Gabrielli, S.
    Perrone, S.
    Barberi, W.
    Torelli, G. F.
    Natalino, F.
    Scalzulli, E.
    Totino, V.
    Foa, R.
    Cancrini, G.
    Girmenia, C.
    TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (04) : 625 - 630
  • [8] Use of checkpoint inhibitors (CPI) in allogeneic stem cell transplant recipients: An institutional experience and a systemic review of the literature
    Saberian, C.
    Abdel-Wahab, N.
    Suarez-Almazor, M.
    Al-Atrash, G.
    Aabudayyeh, A.
    Diab, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 529 - 529
  • [9] Mucormycosis in lung transplant recipients: A systematic review of the literature and a case series
    Wand, Ori
    Unterman, Avraham
    Izhakian, Shimon
    Fridel, Ludmila
    Kramer, Mordechai R.
    CLINICAL TRANSPLANTATION, 2020, 34 (02)
  • [10] Cerebral toxoplasmosis in an allogeneic peripheral stem cell transplant recipient: case report and review of literature
    Cibickova, L.
    Horacek, J.
    Prasil, P.
    Slovacek, L.
    Kohout, A.
    Cerovsky, V.
    Hobza, V.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (04) : 332 - 335